Bone Biologics Corp — Form D

Bone Biologics Corp of BURLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-23. The offering totals $5.9M, of which $5.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
John R BoothDirectorBurlington, MA
Jimmy R DelshadDirectorBurlington, MA
Bret R HankeyDirectorBurlington, MA
Don R HankeyDirectorBurlington, MA
Stephen R LaNeveDirectorBurlington, MA
Bruce R StroeverDirectorBurlington, MA
Jeff R FrelickExecutive OfficerBurlington, MA
Stephen R LaNeveExecutive OfficerBurlington, MA
Deina R WalshExecutive OfficerBurlington, MA
John BoothDirectorSAINT-SAUVEUR, A8
Deina H WalshExecutive OfficerBurlington, MA
Siddhesh R AngleDirectorBurlington, MA
Erick R LuceraDirectorBurlington, MA
Jeffrey FrelickExecutive OfficerBurlington, MA
Benjamin WuDirectorNew York, NY
JEFFREY R FRELICKExecutive OfficerBurlington,, MA
Chia SooDirectorBoston, MA
Jimmy DelshadDirectorBoston, MA
William CoffinDirectorBoston, MA
Bruce StroeverDirectorBoston, MA
Jeff FrelickExecutive OfficerBoston, MA
Deina WalshExecutive OfficerBoston, MA
Steve La NeveExecutive OfficerBoston, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-11-29D$729K$729K
2018-03-30D/A$10.0M$1.9M
2017-08-30D$10.0M$1.4M
2016-03-23D$4.5M

More